After determining last week that Stratagene's quantitative PCR and RT-PCR reagents infringe two patents held by Third Wave Technologies, a US District Court jury in Wisconsin has awarded Third Wave $5.29 million in damages.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.